# Remote Monitored Systems Pharm to Farm to make masks available in UK & Europe via Amazon

- Link: https://www.directorstalkinterviews.com/remote-monitored-systems-pharm-to-farm-to-make-masks-available-in-uk-europe-via-amazon/412965617
- Published: 2021-03-04T07:16:42+00:00
- Author: Giles

**Remote Monitored Systems plc** ([LON:RMS](https://www.directorstalkinterviews.com/company/remote-monitored-systems-plc/rms.l))
has reported the significant progress achieved since the announcement on 18 February.

·  Order for 1.0 million of P2F’s masks placed with Volz with outsourcing manufacturing
discussions in progress

·    Distribution agreement to make masks available in UK & Europe via Amazon

·    Launch of web site for the P2F mask

·    Independent adviser and line manager appointed to bring mask machine into full
operation

Further to previous announcements in relation to discussions the Company has held
with the Volz Group of Companies, an initial order has been placed for one million
of P2F’s masks, incorporating P2F’s proprietary antiviral material (α-virion), and
discussions are under way to extend this into a production outsourcing arrangement
to increase the supply of the anti-viral masks.  Not only should this approach enable
the expected demand for the mask to be met but it will also allow P2F to focus on
its core strengths of developing and producing nanomaterials and associated innovative
products.

Whilst interest in the masks has been strong, it was important to ensure that potential
supply issues had been resolved before committing to deliveries.  On the back of
the discussions with Volz, P2F has entered into a distribution agreement with Francis
McIntyre Limited, an online garment retailer with the brand FM London, to make P2F’s
masks available to customers across the UK and Europe via the Amazon E-commerce 
platform.  Under the terms of the agreement, Francis McIntyre has placed an initial
order for 100,000 masks, with the exclusive right to sell via Amazon being conditional
upon Francis McIntyre ordering a minimum of 1 million masks per month.  P2F has 
also started supplying batches of between 5,000 and 10,000 masks to a number of 
customers looking to trial the product ahead of potentially placing larger orders
in the future.  A dedicated website for the mask has been created ([www.pro-larva.com](http://www.pro-larva.com/))
and is expected to go live by the end of this week, which should help drive further
demand.

P2F is in discussions with Lemu Group, the manufacturer of the mask making machine,
regarding mechanical issues that need to be resolved before the machine at BioCity
can be considered to be fully commissioned.  The Company has agreed to appoint Egremont
Capital Limited (“Egremont”) as an independent advisor for the next three months
to assist with development of P2F’s production capabilities.  Jonathan Hall, Egremont’s
founder, has a background in production manufacturing, in addition to Egremont’s
expertise as a corporate advisor.  In addition to a monthly fee, Egremont may be
issued with up to 500,000 new ordinary shares dependent on achieving certain production
milestones.  In addition, a line manager has been recruited at BioCity to strengthen
the production team. 

> **Antony Legge, Executive Chairman of Remote Monitored Systems, said;** “We are
> very pleased to update the market with the positive developments achieved by the
> P2F team. Whilst a number of issues remain with the machine at BioCity, the purchase
> order with Volz coupled with the intentions by both parties to enter into a more
> formal outsourced manufacturing agreement, means P2F can commence sales with confidence
> as we anticipate a continuing market need for P2F’s proprietary α-virion material,
> notwithstanding the progress of various national Covid-19 vaccination programmes.”

Share on: